The cumulative incidence of hospitalization for COPD (Log-rank test p-value < 0.001), bacterial pneumonia (Log-rank test p-value < 0.001), and IMV (Log-rank test p-value < 0.001) were significantly higher in insulin users than in non-users (Figure 2). This evidence concerns the gene INS and chronic obstructive pulmonary disease.